Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics

  25 April 2024

Antimicrobial resistance poses significant challenges for children and neonates, and the World Health Organization (WHO) conducted the first Paediatric Drug Optimisation (PADO) exercise for antibiotics in November and December 2022. The exercise aimed to prioritize antibiotics for paediatric research and development, particularly in regions with high disease burdens due to serious bacterial infections. The review provides an overview of the exercise processes, literature, and follow-up actions, emphasizing the collaborative PADO process’s potential to ensure children’s access to essential medicines worldwide.

Author(s): Alasdair Bamford et al
Effective Surveillance   Kids and Carers  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed